Health & Biotech
Health & Biotech
Weed Week: Iron Mike throws down challenge to Biden, and recent ASX pot winners
Health & Biotech
‘Significant potential’: This ASX stock is winning the race to make cancer care heart-safe
Health & Biotech
Neurotech reports sustained clinical progress in PANDAS/PANS patients during Phase I/II extension study
Health & Biotech
ASX Health Stocks: Sonic slumps after H1 profits fall 47pc. CEO says don’t worry, we’re back to normal now
Health & Biotech
ASX stocks striving to inject youthfulness into an aging world population
Health & Biotech
Fundie Merchant Group picks four biotech stocks that could rip as sector hits rude health again
Health & Biotech
ASX Health Stocks: Starpharma suffers setback as FDA rejects appeal, shares down 10pc
Health & Biotech
LTR Pharma firms up study for erectile dysfunction with patient recruitment
Health & Biotech
ScoPo’s Powerplays: ASX health stocks tumble as CSL bleeds after Phase III trial misses endpoint
Health & Biotech
FDA shows the way for accelerated approval of PharmAust’s monepantel in MND
Health & Biotech
ASX Health Stocks: Clarity’s imaging agent can identify prostate cancer lesions at double the rate
Health & Biotech
Check Up: Aussie biotech Avarax on the verge of peanut allergy cure; and recent ASX health winners
Featured Health & Biotech Stocks
Health & Biotech
Healthcare stocks are as varied as the solutions they are working to solve. The sector covers biotech stocks developing breakthrough pharmaceutical drugs and vaccines to medtech companies launching the latest and greatest medical devices they hope will change the face of healthcare.
Even the ‘budding’ medical cannabis industry is in the mix as researchers explore new applications and treatments.
If you want to know what’s happening with emerging health stocks on the ASX, Stockhead has you covered, with daily stock news, expert insight and research. You can also recap broader industry trends and recent share price movements across the sector in our regular ‘Check Up’ feature.
Accurate, up-to-date news stories are important, especially in the health sector where progress is often slow and risk often high. That’s why we’re focused on helping small cap investors make sense of the medical jargon.